Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 201

    1.

    Trichloroethylene and cancer: epidemiologic evidence

    Scott CS, Cogliano VJ.

    Environ Health Perspect. 2000 May;108 Suppl 2:159-60.PMID: 10807549 [PubMed - as supplied by publisher]Related articles

    2.

    Dose-response analyses of the carcinogenic effects of trichloroethylene in experimental animals.

    Rhomberg LR.

    Environ Health Perspect. 2000 May;108 Suppl 2:343-58. Review.PMID: 10807564 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.

    Evans MV, Chiu WA, Okino MS, Caldwell JC.

    Toxicol Appl Pharmacol. 2009 May 1;236(3):329-40. Epub 2009 Feb 26.PMID: 19249323 [PubMed - indexed for MEDLINE]Related articles

    4.

    Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

    EFSA GMO Panel Working Group on Animal Feeding Trials.

    Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. Epub 2008 Feb 13. Review.PMID: 18328408 [PubMed - indexed for MEDLINE]Related articles

    5.

    Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene.

    Clewell HJ, Andersen ME.

    Crit Rev Toxicol. 2004 Sep-Oct;34(5):385-445. Review.PMID: 15560567 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene.

    Moore MM, Harrington-Brock K.

    Environ Health Perspect. 2000 May;108 Suppl 2:215-23. Review.PMID: 10807553 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Evaluating human variability in chemical risk assessment: hazard identification and dose-response assessment for noncancer oral toxicity of trichloroethylene.

    Barton HA, Flemming CD, Lipscomb JC.

    Toxicology. 1996 Jul 17;111(1-3):271-87. Review.PMID: 8711742 [PubMed - indexed for MEDLINE]Related articles

    8.

    Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.

    Barton HA, Clewell HJ 3rd.

    Environ Health Perspect. 2000 May;108 Suppl 2:323-34. Review.PMID: 10807562 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Metabolism of trichloroethylene.

    Lash LH, Fisher JW, Lipscomb JC, Parker JC.

    Environ Health Perspect. 2000 May;108 Suppl 2:177-200. Review.PMID: 10807551 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Chloroform mode of action: implications for cancer risk assessment.

    Golden RJ, Holm SE, Robinson DE, Julkunen PH, Reese EA.

    Regul Toxicol Pharmacol. 1997 Oct;26(2):142-55. Review.PMID: 9356278 [PubMed - indexed for MEDLINE]Related articles

    11.

    Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.

    Caldwell JC, Keshava N.

    Environ Health Perspect. 2006 Sep;114(9):1457-63. Review.PMID: 16966105 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cancer risk assessment for 1,3-butadiene: data integration opportunities.

    Preston RJ.

    Chem Biol Interact. 2007 Mar 20;166(1-3):150-5. Epub 2006 Apr 5.PMID: 16647696 [PubMed - indexed for MEDLINE]Related articles

    13.

    A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling.

    Cronin WJ 4th, Oswald EJ, Shelley ML, Fisher JW, Flemming CD.

    Risk Anal. 1995 Oct;15(5):555-65.PMID: 7501875 [PubMed - indexed for MEDLINE]Related articles

    14.

    Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses.

    Schlosser PM, Lilly PD, Conolly RB, Janszen DB, Kimbell JS.

    Risk Anal. 2003 Jun;23(3):473-87.PMID: 12836840 [PubMed - indexed for MEDLINE]Related articles

    15.
    16.

    Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

    Clewell HJ 3rd, Gentry PR, Covington TR, Gearhart JM.

    Environ Health Perspect. 2000 May;108 Suppl 2:283-305. Review.PMID: 10807559 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.

    Bogen KT, Gold LS.

    Regul Toxicol Pharmacol. 1997 Feb;25(1):26-42. Review.PMID: 9056499 [PubMed - indexed for MEDLINE]Related articles

    18.

    Issues in the pharmacokinetics of trichloroethylene and its metabolites.

    Chiu WA, Okino MS, Lipscomb JC, Evans MV.

    Environ Health Perspect. 2006 Sep;114(9):1450-6. Review.PMID: 16966104 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.

    Willhite CC, Ball GL, McLellan CJ.

    J Toxicol Environ Health B Crit Rev. 2008 Feb;11(2):69-146. Review.PMID: 18188738 [PubMed - indexed for MEDLINE]Related articles

    20.

    Biomarkers in aquatic plants: selection and utility.

    Brain RA, Cedergreen N.

    Rev Environ Contam Toxicol. 2009;198:49-109. Review.PMID: 19253039 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data